• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical trials in bipolar mania: implications in study design and drug development.

作者信息

Tohen Mauricio

机构信息

Lilly Research Laboratories, Eli Lilly Corporate Center, Indianapolis, IN 46285, USA.

出版信息

Arch Gen Psychiatry. 2008 Mar;65(3):252-3. doi: 10.1001/archgenpsychiatry.2007.44.

DOI:10.1001/archgenpsychiatry.2007.44
PMID:18316671
Abstract
摘要

相似文献

1
Clinical trials in bipolar mania: implications in study design and drug development.双相躁狂症的临床试验：对研究设计和药物开发的影响
Arch Gen Psychiatry. 2008 Mar;65(3):252-3. doi: 10.1001/archgenpsychiatry.2007.44.
2
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.蛋白激酶C抑制在躁狂症治疗中的作用：他莫昔芬的双盲、安慰剂对照试验
Arch Gen Psychiatry. 2008 Mar;65(3):255-63. doi: 10.1001/archgenpsychiatry.2007.43.
3
Concomitant use of Lorazepam with tamoxifen in bipolar mania clinical trials.在双相躁狂症临床试验中劳拉西泮与他莫昔芬的联合使用。
Arch Gen Psychiatry. 2009 Jan;66(1):107-8; author reply 108-9. doi: 10.1001/archgenpsychiatry.2008.505.
4
Quality of reporting controlled clinical trials on treatment of the acute mania phase of bipolar disorder with new antipsychotic drugs.关于新型抗精神病药物治疗双相情感障碍急性躁狂期的对照临床试验的报告质量
Pharmacopsychiatry. 2008 Nov;41(6):240-1. doi: 10.1055/s-0028-1083817. Epub 2008 Dec 9.
5
Tamoxifen: A Protein Kinase C Inhibitor to Treat Mania: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials.他莫昔芬：一种用于治疗躁狂症的蛋白激酶C抑制剂：随机安慰剂对照试验的系统评价和荟萃分析
J Clin Psychopharmacol. 2016 Jun;36(3):272-5. doi: 10.1097/JCP.0000000000000492.
6
Clinical decision making in the treatment of mania.躁狂症治疗中的临床决策
J Clin Psychiatry. 2008;69 Suppl 5:16-21.
7
Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?双相情感障碍的观察性研究设计——它们能告诉我们关于急性躁狂症治疗的哪些信息？
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):715-21. doi: 10.1016/j.pnpbp.2009.03.024. Epub 2009 Apr 2.
8
Comment to Dr. Yatham regarding tamoxifen listed as a third-line recommendation for the pharmacological treatment of acute mania.致亚瑟姆博士的关于他将他莫昔芬列为急性躁狂症药物治疗三线推荐药物的评论。
Bipolar Disord. 2009 Nov;11(7):773-5; author reply 775. doi: 10.1111/j.1399-5618.2009.00747.x.
9
Kinases as drug targets in the treatment of bipolar disorder.激酶作为双相情感障碍治疗中的药物靶点。
Drug Discov Today. 2008 Apr;13(7-8):295-302. doi: 10.1016/j.drudis.2008.02.007. Epub 2008 Apr 3.
10
On being bipolar without being bipolar.关于并非双相情感障碍却呈现双相情感障碍症状的情况。
J Psychopharmacol. 2008 Jun;22(4):402-3; discussion 408. doi: 10.1177/0269881108092123.

引用本文的文献

1
Suicidality and Illness Course Worsening in a Male Patient with Bipolar Disorder during Tamoxifen Treatment for ER+/HER2+ Breast Cancer.一名雌激素受体阳性/人表皮生长因子受体2阳性乳腺癌男性患者在他莫昔芬治疗期间双相情感障碍的自杀倾向及病情恶化
Case Rep Psychiatry. 2021 Mar 24;2021:5547649. doi: 10.1155/2021/5547649. eCollection 2021.
2
Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design.双相情感障碍的治疗指南及恰当临床试验设计的重要性。
Int J Neuropsychopharmacol. 2017 Feb 1;20(2):95-97. doi: 10.1093/ijnp/pyx002.
3
Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.
蛋白激酶C抑制剂：用于治疗双相情感障碍的理论依据及潜力
CNS Drugs. 2009;23(7):569-82. doi: 10.2165/00023210-200923070-00003.
4
A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.蛋白激酶C作为双相情感障碍药物开发靶点的临床前和临床证据综述。
Curr Psychiatry Rep. 2008 Dec;10(6):510-9. doi: 10.1007/s11920-008-0081-7.